全文获取类型
收费全文 | 21060篇 |
免费 | 1659篇 |
国内免费 | 266篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 520篇 |
妇产科学 | 397篇 |
基础医学 | 1006篇 |
口腔科学 | 768篇 |
临床医学 | 2991篇 |
内科学 | 3939篇 |
皮肤病学 | 439篇 |
神经病学 | 864篇 |
特种医学 | 545篇 |
外科学 | 1358篇 |
综合类 | 2030篇 |
现状与发展 | 6篇 |
预防医学 | 4802篇 |
眼科学 | 303篇 |
药学 | 1472篇 |
19篇 | |
中国医学 | 632篇 |
肿瘤学 | 828篇 |
出版年
2024年 | 37篇 |
2023年 | 399篇 |
2022年 | 517篇 |
2021年 | 999篇 |
2020年 | 1209篇 |
2019年 | 903篇 |
2018年 | 903篇 |
2017年 | 784篇 |
2016年 | 803篇 |
2015年 | 697篇 |
2014年 | 1366篇 |
2013年 | 2091篇 |
2012年 | 1064篇 |
2011年 | 1213篇 |
2010年 | 1037篇 |
2009年 | 958篇 |
2008年 | 955篇 |
2007年 | 975篇 |
2006年 | 936篇 |
2005年 | 775篇 |
2004年 | 631篇 |
2003年 | 562篇 |
2002年 | 505篇 |
2001年 | 393篇 |
2000年 | 295篇 |
1999年 | 292篇 |
1998年 | 246篇 |
1997年 | 184篇 |
1996年 | 213篇 |
1995年 | 149篇 |
1994年 | 103篇 |
1993年 | 117篇 |
1992年 | 84篇 |
1991年 | 63篇 |
1990年 | 59篇 |
1989年 | 55篇 |
1988年 | 69篇 |
1987年 | 44篇 |
1986年 | 36篇 |
1985年 | 37篇 |
1984年 | 40篇 |
1983年 | 31篇 |
1982年 | 24篇 |
1981年 | 32篇 |
1980年 | 17篇 |
1979年 | 15篇 |
1978年 | 9篇 |
1977年 | 18篇 |
1976年 | 14篇 |
1975年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
23.
Walid K. Abu Saleh Phillip Mason Odeaa Al Jabbari Hany Samir Brian A. Bruckner 《Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital》2015,42(6):569-571
The Impella 5.0, a percutaneously inserted left ventricular assist device, has been used to support patients who have severe heart failure or who are undergoing high-risk percutaneous coronary intervention. We report our surgical placement of the Impella 5.0, through a graft sewn to the aorta, to unload the left ventricle of a 59-year-old man who was undergoing venoarterial extracorporeal membrane oxygenation for postcardiotomy shock. The patient underwent successful placement of a long-term left ventricular assist device before his discharge from the hospital. The versatility of the Impella 5.0 is exemplified in this patient who was successfully bridged to long-term support. 相似文献
24.
25.
Chung S. Yang Philip Luo Zishuo Zeng Hong Wang Mokenge Malafa Nanjoo Suh 《Molecular carcinogenesis》2020,59(4):365-389
α-Tocopherol (α-T) is the major form of vitamin E (VE) in animals and has the highest activity in carrying out the essential antioxidant functions of VE. Because of the involvement of oxidative stress in carcinogenesis, the cancer prevention activity of α-T has been studied extensively. Lower VE intake or nutritional status has been shown to be associated with increased cancer risk, and supplementation of α-T to populations with VE insufficiency has shown beneficial effects in lowering the cancer risk in some intervention studies. However, several large intervention studies with α-T conducted in North America have not demonstrated a cancer prevention effect. More recent studies have centered on the γ- and δ-forms of tocopherols and tocotrienols (T3). In comparison with α-T, these forms have much lower systemic bioavailability but have shown stronger cancer-preventive activities in many studies in animal models and cell lines. γ-T3 and δ-T3 generally have even higher activities than γ-T and δ-T. In this article, we review recent results from human and laboratory studies on the cancer-preventive activities of different forms of tocopherols and tocotrienols, at nutritional and pharmacological levels. We aim to elucidate the possible mechanisms of the preventive actions and discuss the possible application of the available information for human cancer prevention by different VE forms. 相似文献
26.
27.
28.
29.
A study was undertaken of all drowning deaths that occurred over a 30-year period from 1988 to 2017 in the urban section of the River Torrens, Adelaide, South Australia, an augmented waterway that runs through the central business district. Autopsy records from Forensic Science South Australia (FSSA) were reviewed. There were 34 drownings (0–5 cases/yr) with 28 males and 6 females (M;F = 4.6:1), with an age range for males of 18-76yrs (mean 42.0; SD 18.0) and for females of 20-84yrs (mean 69.3; SD 24.5). There were 15 (44%) accidents, 11 (32%) suicides, 1 (3%) homicide and 7 (21%) undetermined. Of the 22 cases during or after 1994 with complete toxicology reports, 10 (45%) had a blood alcohol concentration (BAC) of greater than 0.05% (g/100 mL) with an illicit substance detected in 4 (18%) cases: (MDMA (3,4-methylenedioxymethamphetamine), methylamphetamine and THC (delta-9-tetrahydrocannabinol) acid). The presence of various therapeutic drugs was also detected in 10 cases (45%) including temazepam, fluoxetine, diazepam, olanzapine, amitriptyline, carbamazepine, codeine, citalopram and valproate. Although the numbers of cases were not high, the urban portion of the River Torrens had a much higher number of drowning events per kilometre compared to other inland waterways in South Australia such as the Murray River. This is most likely due to the vulnerability that exists for intoxicated individuals in the city from falls into the water and to the availability of the river as a means of suicide to members of the adjacent urban population. 相似文献
30.
Sameer Arora Kamal Shemisa Muthiah Vaduganathan Arman Qamar Ankur Gupta Sushil K. Garg Dharam J. Kumbhani Helen Mayo Houman Khalili Ambarish Pandey Sandeep R. Das 《Journal of the American College of Cardiology》2019,73(19):2454-2464
Ticagrelor is a cornerstone of modern antithrombotic therapy alongside aspirin in patients with acute coronary syndrome and after percutaneous coronary intervention. Adverse effects such as bleeding and dyspnea have been associated with premature ticagrelor discontinuation, which may limit any potential advantage of ticagrelor over clopidogrel. The randomized trials of ticagrelor captured adverse events, offering the opportunity to more precisely quantify these effects across studies. Therefore, a meta-analysis of 4 randomized clinical trials of ticagrelor conducted between January 2007 and June 2017 was performed to quantify the incidence and causes of premature ticagrelor discontinuation. Among 66,870 patients followed for a median 18 months, premature ticagrelor discontinuation was seen in 25%; bleeding was the most common cause of discontinuation followed by dyspnea. Versus the comparators, the relative risk of dyspnea-related discontinuation during follow-up was 6.4-fold higher, the relative risk of bleeding was 3.2-fold higher, and the relative risk of discontinuation due to any adverse event was 59% higher for patients receiving ticagrelor. Understanding these potential barriers to adherence to ticagrelor is crucial for informed patient-physician decision making and can inform future efforts to improve ticagrelor adherence. This review discusses the incidence, causes, and biological mechanisms of ticagrelor-related adverse effects and offers strategies to improve adherence to ticagrelor. 相似文献